Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dong-Yan Cai"'
Autor:
Ting-Xun Lu, Shuang Wu, Dong-Yan Cai, Ting-Ting Hong, Ying Zhang, Hua-Qiang Gao, Hai-Ying Hua, Xiao-Hong Wu
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Liver function is routinely assessed in clinical practice as liver function tests provide sensitive indicators of hepatocellular injury. However, the prognostic value of enzymes that indicate hepatic injury has never been systemat
Externí odkaz:
https://doaj.org/article/e929e23123794843a2d59324325193b0
Autor:
Ting-Xun, Lu, Shuang, Wu, Xin-Yi, Zhou, Ying, Zhang, Ting-Ting, Hong, Dong-Yan, Cai, Hai-Ying, Hua, Xiao-Wei, Qi, Xiao-Hong, Wu
Publikováno v:
Experimental and molecular pathology. 112
The dual expression of CD5 and MYC protein (DECM) on B-lymphocytes may arise at a specific stage of de novo diffuse large B-cell lymphoma (DLBCL). This study retrospectively reviewed 210 patients with de novo DLBCL at the Affiliated Hospital of Jiang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10f4702ec0cfef5dd506b8fb912ffb85
https://pubmed.ncbi.nlm.nih.gov/31706988
https://pubmed.ncbi.nlm.nih.gov/31706988
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 35(1)
To study the growth inhibition effect of Brucea javanica Fruit Oil Emulsion (BJFOE) on human ovarian caner SKOV3 cells and the transplanted tumor of SKOV3 nude mice.Growth inhibition effects of different concentrations BJFOE alone or its combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb9741fb079f812aa23144b39cd80090
https://pubmed.ncbi.nlm.nih.gov/25790676
https://pubmed.ncbi.nlm.nih.gov/25790676
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 33(7)
To observe the synergistic effect of beta-elemene Injection (betaI) combined Paclitaxel Injection (PI) on breast cancer MB-468 cells and to study possible mechanisms.Breast cancer MB-468 cells were treated with betaI (2.5, 5.0, 10.0, 20.0, 40.0, 80.0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::709f6226d27f847443aa3b8be6483130
https://pubmed.ncbi.nlm.nih.gov/24063225
https://pubmed.ncbi.nlm.nih.gov/24063225
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 34(2)
To compare the efficacy of second-line EGFR-TKIs followed by third-line pemetrexed with second-line pemetrexed followed by third-line EGFR-TKIs in patients with advanced lung adenocarcinoma.From March 2007 to August 2008, 83 patients with advanced lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::902b37ca689667a2a1a11aa39bb449e1
https://pubmed.ncbi.nlm.nih.gov/22780936
https://pubmed.ncbi.nlm.nih.gov/22780936
Publikováno v:
Cancer investigation. 29(7)
We evaluated cancer risk with three VEGF polymorphisms (-460CT, -2578CA, 1612GA) based on current available studies. -460CT did not appear to influence cancer risks. -2578C carriers had a 30% reduction of colorectal cancer (CRC) risk in comparison wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea65db894e280c7e8f991c8a9e44ab10
https://pubmed.ncbi.nlm.nih.gov/21740084
https://pubmed.ncbi.nlm.nih.gov/21740084